There has been some confusion regarding the taxonomy of spikenard [1] . Two species of Nardostachys from the Indian Himalayan region have been described, N. grandiflora DC. and N. jatamansi (D. Don) DC., although these two have been considered conspecific [2] . Two other species of Nardostachys have been described, N. chinensis and N. gracilis [1] , but these have also been lumped together in N. jatamansi [2b] . N. jatamansi is commonly called "Indian nard", "balchar" (Urdu), "spikenard" (English), "gansong" (Chinese), "kanshoko" (Japanese), and "jatamansi" (Nepali).
Nardostachys is a perennial, dwarf, hairy, rhizomatous herb, densely covered with fibrous or lamellar remains of old sheaths. The plant is distributed in the Himalayan region of Nepal, China, Bhutan, and India from 2200-5000 m above sea level [2b] . N. grandiflora and N. jatamansi are both used for the production of essential oils [3] , and the two species can be distinguished anatomically by the thickness of periclinal epidermal cell wall beneath the cuticle in the leaf residue and by the presence or absence of schlerenchyma cells in the pith of rhizome [4] . N. jatamansi is listed in CITES (Convention on International Trade of Endangered Species) in Nepal and India [2b], but is one of the major exported herbs from Nepal [3b].
In India, N. jatamansi is traditionally used in treatment of sleeping disorders, nervous disorders, for its stimulating effect, as a bitter tonic, antipyretic, antispasmodic, and antiseptic [2b,5]. In China, N. chinensis (= N. jatamansi) is used for stomachic and sedative effects [6] . Traditionally in Nepal N. jatamansi has been used in treatment of epilepsy, hysteria, convolutions, heart palpitations, intestinal colic, and antiarrhythmic activities and is an important component in Ayurvedic formulations [7] . This historically important herb is mentioned in the Bible, Quoran, and Sushruta Samhita [8] .
Pharmacologically, N. jatamansi has shown antioxidant activity [9], hepatoprotective activity [10] , cardiotonic, antihyperlipidemic, respiratory [11], hair growth [12] , and antihyperglycemic effects [13] . N. jatamansi has been shown to be a neuroeffective drug; it helps in improving learning disorders, alleviating aggressiveness, stubbornness, restlessness, and insomnia, and it has fewer side effects and is more efficient than commercially available drugs like amphetamine and chlorpromazine [14] . Methanolic and aqueous extracts have shown pronounced activity against amnesia and dementia in mice [15] . N. jatamansi has shown insecticidal activity against Sitophylus zeamais, and Tribolium castaneum [16] .
Several coumarins and sesquiterpenoids have been isolated and identified from N. jatamansi extracts [17] , including 9-aristolen-1ol, 1,2,9,10-tetrahydro-aristolan [18] , nardosinone, spirojatamol [19] , jatamol A, jatamol B [20] , jatamansol, jatamansic acid, dihyrodojatamansin, nardostachone [21] , jatamansinone, oroselol, oroselone, velaranal, and seselinardostachysin [22] . In this present work, we report the essential oil composition and biological activities of the essential oil from the rhizome of N. grandiflora from Nepal.
The essential oil from the dried rhizome of Nardostachys grandiflora was obtained in 1.4% yield, and a total of 72 compounds were identified constituting 93.8% of the essential oil ( Table 1 ). The rhizome essential oil of N. grandiflora was mostly composed of calarene (9.4%), valerena-4,7(11)-diene (7.1%), nardol A (6.0%), 1(10)-aristolen-9β-ol (11.6%), jatamansone (7.9%), valeranal (5.6%), and cis-valerinic acid (5.7%). There have been several reports on essential oils from N. jatamansi. α-Selinene (9.2%), nardol (10%), dihydro-β-ionone (7.9%) were found in N. jatamansi from India [23] . In another report from India, jatamansone (36.7%) and α-cadinol (22.7%) were found as the major constituents of N. jatamansi [24] , while another reported β-gurjunene (20.6%), maaliol (8.2%), patchouli alcohol (5.9%), 9-aristolan-12-ol (5.8%) [25] . Ledene oxide II (13%), patchouli alcohol (9.5%) were reported from N. jatamansi from Pakistan [26] . The major essential oil component, 1(10)-aristolen-9β-ol ( Figure 1 ) was isolated by silica gel column chromatography and the structure determined by NMR. The compound was isolated as colorless crystals. 1 H NMR showed the presence of four methyl signals at δH 0.99 (s), 1.10 (s), 0.97 (d, J=6.5Hz), and 1.01. The hydrogen at C(9) appeared at 4.33 (ddt) whereas the H(1) appeared at 5.56 (dt). The structure was established by comparison of 1 H and 13 C spectra to those reported in the literature [27] and was further verified using gCOSY, gc2HMBC, gc2HSQCse and NOESY correlations. The stereochemistry of H(9) was confirmed using NOESY spectra that showed correlations to H (15) , H (7) and H (8) . To differentiate the species of Nardostachys, a chemical study was conducted in Japan which concluded that N. chinensis is composed of calarene (38%), β-maaline (8%), patchouli alcohol (4.5%) but N. grandiflora was composed of jatamansone (30.9%) and spirojatamol (26.9%) as the major components [3a] . A more recent analysis of Chinese N. chinensis showed calarene (25.9%), patchouli alcohol (10.6%), α-gurjunene (7.5%), aristolone (7.1%), β-maaline (6.5%), and spathulenol (4.3%) [16] , which is consistent with previously reported compositions of N. chinensis from China [3a,28] . Apparently the chemical composition of Chinese N. chinensis is remarkably different from Indian or Pakistani N. jatamansi or from Nepalese N. grandiflora.
NPC Natural Product Communications
The chemical differences in Nardostachys essential oils are not unexpected; plants often produce different qualitative and quantitative concentrations of phytochemicals when grown in different geographical locations. These differences can be attributed to differences in environmental, climatic, and ecological conditions between India, Nepal, and China. It is well known that the quantitative composition and the relative proportions of the oil components are widely influenced by the genotype, ontogenic development, and the environmental and growing conditions. The N. grandiflora essential oil and the major component, 1(10)aristolen-9β-ol, were screened for antimicrobial activity against Bacillus cereus, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and Candida albicans, and for cytotoxicity against human MCF-7 breast tumor cells (Table 2) . and a voucher specimen (number 1314081) has been deposited in the KATH herbarium, Kathmandu, Nepal. The air-dried rhizome sample (500 g) was crushed and hydro-distilled using a Clevenger type apparatus for 4 h to give a bluish green essential oil (7 g), which was stored at 4ºC until analysis.
Gas Chromatography -Mass Spectrometry: N. grandiflora rhizome oil was subjected to GC-MS analysis on an Agilent model 6890 gas chromatograph, an Agilent 5973 mass selective detector, and HP-5ms column as previously described [30] . Identification of the constituents of the volatile oil was achieved based on their retention data (retention indices) determined with reference to C 10 -C 40 n-alkane homologous series, and by comparison of their mass spectral fragmentation patterns with those reported in the literature [31] and stored on the MS library (NIST 11, WILEY 10, FFNSC version 1.2). The percentages of each component are reported as raw percentages based on total ion current without standardization.
Antimicrobial Screening:
The essential oil and the major component were screened for antimicrobial activity against using the microbroth dilution technique as previously described [30] .
Cytotoxicity Screening:
The essential oil and the major component were screened for cytotoxic activity against human MCF-7 breast adenocarcinoma cells (ATCC No. HTB-22) using the MTT assay for cell viability as previously described [30] .
Isolation of 1(10)-Aristolen-9β-ol:
A sample of the essential oil (6.9 g) was subjected to preparative flash chromatography on a silica gel column (55 cm L  4 cm D) eluting with a hexane/ethyl acetate step gradient (100% hexane, 1000 mL; 20% EtOAc, 250 mL; 40% EtOAc, 250 mL, 60% EtOAc 500 mL; 80% EtOAc 250 mL, and 100% EtOAc 250 mL). A total of 50 fractions (50-ml each) were collected; fractions analyzed by GC-MS. Fraction 40-45 contained the major unknown component, which was further purified by column chromatography on 25 g of silica gel eluting with 1:1 hexane/ethyl acetate. The purified compound (85 mg) was identified by NMR and MS to be 1(10)-aristolen-9β-ol.
